Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer's disease.
Chatterjee P, Pedrini S, Stoops E, Goozee K, Villemagne VL, Asih PR, Verberk IMW, Dave P, Taddei K, Sohrabi HR, Zetterberg H, Blennow K, Teunissen CE, Vanderstichele HM, Martins RN. · 2021
Read Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer's disease. by Chatterjee P, Pedrini S, Stoops E, Goozee K, Villemagne VL, Asih PR, Verberk IMW, Dave P, Taddei K, Sohrabi HR, Zetterberg H, Blennow K, Teunissen CE, Vanderstichele HM, Martins RN. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7801513.txt.
Description
Chatterjee and co-authors test a blood marker of brain astrocyte damage in older adults at risk of Alzheimer's disease. The marker is glial fibrillary acidic protein, or GFAP. It can be measured in blood samples. The team studied cognitively normal adults aged 65–90 years. Brain amyloid scans split them into low and high load groups.
The high amyloid group held 33 people, and the low group 63. Plasma GFAP was far higher in the high group. The blood amyloid ratio was lower there too. Adding GFAP lifted the sorting accuracy of the test model. The score rose from 0.78 to 0.91. The authors say astrocyte change starts before symptoms appear.
Catalog record
| CREATOR | Chatterjee P, Pedrini S, Stoops E, Goozee K, Villemagne VL, Asih PR, Verberk IMW, Dave P, Taddei K, Sohrabi HR, Zetterberg H, Blennow K, Teunissen CE, Vanderstichele HM, Martins RN. |
|---|---|
| YEAR | 2021 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |